Search Results - "DE VROEY, V"

MON-PP075: A Unique Definition to Predict Early Stage Cachexia by Ambulatory Cancer Patients by Meulemans, E, Wouters, K, Sels, M, De Keersmaecker, S, Verschueren, C, Bartolomeeussen, L, De Vroey, V, De Clerck, L, Aerts, P, Vanhoutte, G, Baert, D, Vandoninck, C, Kindt, S, Schelfhaut, S, Troch, A, Ceulemans, L, Vandenbergh, H, Rondou, T, Dewitte, E, Maes, K, De Winter, B, Van Gaal, L, Ysebaert, D, Peeters, M

Get full text

Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations by Van Laethem, K, Van Vaerenbergh, K, Schmit, J C, Sprecher, S, Hermans, P, De Vroey, V, Schuurman, R, Harrer, T, Witvrouw, M, Van Wijngaerden, E, Stuyver, L, Van Ranst, M, Desmyter, J, De Clercq, E, Vandamme, A M

“…The sensitivity and discriminatory power of the 151 and 215 amplification refractory mutation system (ARMS) were evaluated, and their performance for the…”
Get full text

Prevalence of Protease and Reverse Transcriptase Drug Resistance Mutations over Time in Drug-Naïve Human Immunodeficiency Virus Type 1-Positive Individuals in Rio de Janeiro, Brazil by DUMANS, Ana T, SOARES, Marcelo A, PIENIAZEK, Danuta, KALISH, Marcia L, DE VROEY, Veronique, HERTOGS, Kurt, TANURI, Amilcar

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Testing Genotypic and Phenotypic Resistance in Human Immunodeficiency Virus Type 1 Isolates of Clade B and Other Clades from Children Failing Antiretroviral Therapy by BRINDEIRO, Patricia A, BRINDEIRO, Rodrigo M, TANURI, Amilcar, MORTENSEN, Claudio, HERTOGS, Kurt, DE VROEY, Veronique, RUBINI, Norma P. M, SION, Fernando S, DE SA, Carlos A. M, MACHADO, Deisy M, SUCCI, Regina C. M

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Resistance to Antiretroviral Therapy Among Patients in Uganda by Weidle, Paul J, Kityo, Cissy M, Mugyenyi, Peter, Downing, Robert, Kebba, Anthony, Pieniazek, Danuta, Respess, Richard, Hertogs, Kurt, De Vroey, Veronique, Dehertogh, Pascale, Bloor, Stuart, Larder, Brendan, Lackritz, Eve

“…OBJECTIVE:To characterize HIV-1 phenotypic resistance patterns and genotypic mutations among patients taking antiretroviral medications in Uganda. METHODS:We…”
Get full text

Initiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients by Vandamme, A-M, Van Vaerenbergh, K, Schmidt, J C, Schmidt, B, Walter, H, Fontaine, E, Schmitt, M, Van Laethem, K, Rascu, A, De Vroey, V, Gruenke, M, Loew, R, Van Ranst, M, Desmyter, J

“…The introduction of potent combinations of antiviral drugs is a major breakthrough in the treatment of HIV. The strategy to start with triple/quadruple therapy…”
Get full text

Phenotypic Assays and Sequencing Are Less Sensitive Than Point Mutation Assays for Detection of Resistance in Mixed HIV-1 Genotypic Populations by Van Laethem, K., Van Vaerenbergh, K., Schmit, J.-C., Sprecher, S., Hermans, P., De Vroey, V., Schuurman, R., Harrer, T., Witvrouw, M., Van Wijngaerden, E., Stuyver, L., Van Ranst, M., Desmyter, J., De Clercq, E., Vandamme, A.-M.

Get full text

A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V by HERTOGS, K, BLOOR, S, MILLER, V, LARDER, B. A, DE VROEY, V, VAN DEN EYNDE, C, DEHERTOGH, P, VAN CAUWENBERGE, A, STÜRMER, M, ALCORN, T, WEGNER, S, VAN HOUTTE, M

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text